Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients

Clinical trial NCT04269369 · UNKNOWN

Trial details

NCT number: NCT04269369
Sponsor: Jessa Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Colon Cancer Stomach Tumor Anal Tumor Pancreas Cancer Esophageal Cancer

Start date: 2020-02-18
Primary completion: 2021-09-30
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.